Skip to main content

Table 2 Distribution of presumed causes of kidney diseases in the 753 haemodialysis patients with or without metabolic syndrome

From: Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes

 

MetS+

MetS-

Diabetes, n(%)

205 (40)

25 (10)

Glomerulonephritis, n(%)

69 (13)

63 (27)

Hypertension, n(%)

44 (9)

22 (9)

Unknown, n(%)

48 (9)

25 (10)

Polycystic, n(%)

33 (6)

18 (8)

Pyelonephritis, n(%)

16 (3)

14 (6)

Vascular, n(%)

7 (1)

0

Autre, n(%)

94 (18)

70 (30)

Total

516 (100)

237 (100)

  1. MetS Metabolic syndrome